The landscape of dementia prognosis has evolved significantly with the arrival of advanced biomarkers, which include amyloid PET scans, tau imaging, and blood-based exams which will detect Alzheimer's pathology many years ahead of indications emerge. Although these technological advancements stand for outstanding progress in knowledge neurodegenera